Stock RPGLIFE RPG LIFE SCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials RPG Life Sciences Limited

Equities

RPGLIFE

INE105J01010

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 11:02:08 28/06/2024 BST 		5-day change 1st Jan Change
1,642 INR +2.05% Intraday chart for RPG Life Sciences Limited +4.85% +22.94%
05-02 RPG Life Sciences Limited Seeks Acquisitions CI
05-02 Transcript : RPG Life Sciences Limited, Q4 2024 Earnings Call, May 02, 2024

Valuation

Fiscal Period: Maart 2019 2020 2021 2022 2023 2024
Capitalization 1 4,099 2,808 6,407 9,269 11,585 25,279
Enterprise Value (EV) 1 4,460 2,920 6,024 8,581 10,437 24,020
P/E ratio 37.9 x 9.68 x 16 x 18 x 17.1 x 28.8 x
Yield 0.97% 2.36% 1.86% 1.71% 1.71% 1.05%
Capitalization / Revenue 1.24 x 0.75 x 1.65 x 2.11 x 2.26 x 4.34 x
EV / Revenue 1.35 x 0.78 x 1.55 x 1.95 x 2.04 x 4.13 x
EV / EBITDA 13.4 x 5.19 x 8.81 x 10.1 x 10.2 x 18.9 x
EV / FCF 20.5 x 10.7 x 16.4 x 24.5 x 21.4 x 108 x
FCF Yield 4.89% 9.36% 6.1% 4.08% 4.68% 0.92%
Price to Book 2.55 x 1.59 x 2.96 x 3.62 x 3.77 x 6.74 x
Nbr of stocks (in thousands) 16,539 16,539 16,539 16,539 16,539 16,539
Reference price 2 247.8 169.8 387.4 560.4 700.4 1,528
Announcement Date 06/07/19 28/07/20 07/08/21 07/07/22 13/07/23 24/06/24
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Maart 2019 2020 2021 2022 2023 2024
Net sales 1 3,302 3,756 3,891 4,402 5,128 5,820
EBITDA 1 332.6 563.1 683.5 846.2 1,020 1,271
EBIT 1 186.9 429.5 536.6 707.4 881 1,111
Operating Margin 5.66% 11.44% 13.79% 16.07% 17.18% 19.08%
Earnings before Tax (EBT) 1 150.5 364.5 535.8 731.7 916.8 1,178
Net income 1 108.1 290.1 400 514.8 676.4 876.6
Net margin 3.27% 7.72% 10.28% 11.7% 13.19% 15.06%
EPS 2 6.536 17.54 24.19 31.13 40.90 53.00
Free Cash Flow 1 218 273.4 367.7 350.4 488 222
FCF margin 6.6% 7.28% 9.45% 7.96% 9.52% 3.81%
FCF Conversion (EBITDA) 65.54% 48.55% 53.8% 41.41% 47.84% 17.46%
FCF Conversion (Net income) 201.64% 94.24% 91.93% 68.06% 72.14% 25.33%
Dividend per Share 2 2.400 4.000 7.200 9.600 12.00 16.00
Announcement Date 06/07/19 28/07/20 07/08/21 07/07/22 13/07/23 24/06/24
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 361 112 - - - -
Net Cash position 1 - - 383 689 1,148 1,259
Leverage (Debt/EBITDA) 1.086 x 0.1985 x - - - -
Free Cash Flow 1 218 273 368 350 488 222
ROE (net income / shareholders' equity) 6.86% 17.2% 20.4% 21.8% 24% 25.7%
ROA (Net income/ Total Assets) 4.31% 10.4% 11.8% 13.6% 14.4% 14.9%
Assets 1 2,510 2,799 3,400 3,773 4,692 5,885
Book Value Per Share 2 97.00 107.0 131.0 155.0 186.0 227.0
Cash Flow per Share 2 0.2200 0.3300 24.40 34.40 15.00 11.90
Capex 1 197 107 85.1 240 327 692
Capex / Sales 5.96% 2.86% 2.19% 5.44% 6.38% 11.89%
Announcement Date 06/07/19 28/07/20 07/08/21 07/07/22 13/07/23 24/06/24
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
RPG LIFE SCIENCES LIMITED Stock RPG Life Sciences Limited
+22.94% 319M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.95% 819B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.23% 638B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.98% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.08% 329B
ABBVIE INC. Stock AbbVie Inc.
+9.05% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.17% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.78% 225B
NOVARTIS AG Stock Novartis AG
+13.31% 217B
AMGEN INC. Stock Amgen Inc.
+8.91% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. RPGLIFE Stock
  4. Financials RPG Life Sciences Limited